![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 47, 44212-44221, November 23, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶,
**, and


From the
Programme in Cell Biology, The Hospital for
Sick Children, Toronto, Ontario M5G 1X8 and
Department of
Biochemistry, University of Toronto,
Toronto, Ontario M5S 1A8, Canada
Received for publication, April 4, 2001, and in revised form, September 11, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Insulin enhances plasmalemmal-directed traffic of
glucose transporter-4 (GLUT4), but it is unknown whether insulin
regulates GLUT4 traffic through endosomal compartments. In L6 myoblasts expressing Myc-tagged GLUT4, insulin markedly stimulated the rate of
GLUT4myc recycling. In myoblasts stimulated with insulin to maximize
surface GLUT4myc levels, we followed the rates of surface-labeled GLUT4myc endocytosis and chased its intracellular distribution in space
and time using confocal immunofluorescence microscopy. Surface-labeled
GLUT4myc internalized rapidly (t1/2 3 min),
reaching the early endosome by 2 min and the transferrin receptor-rich,
perinuclear recycling endosome by 20 min. Upon re-addition of insulin,
the t1/2 of GLUT4 disappearance from the plasma
membrane was unchanged (3 min), but strikingly, GLUT4myc reached the
recycling endosome by 10 and left by 20 min. This effect of insulin was
blocked by the phosphatidylinositol 3-kinase inhibitor LY294002 or by
transiently transfected dominant-negative phosphatidylinositol 3-kinase
and protein kinase B mutants. In contrast, insulin did not alter the rate of arrival of rhodamine-labeled transferrin at the recycling endosome. These results reveal a heretofore unknown effect of insulin
to accelerate inter-endosomal travel rates of GLUT4 and identify the
recycling endosome as an obligatory stage in
insulin-dependent GLUT4 recycling.
Transmembrane proteins are constitutively removed from the cell
surface and directed to the early endosome. From here, proteins destined for recycling enter the recycling endosome (1). This pathway
is thought to work in a constitutive fashion, but little is known about
possible regulation of the individual steps, i.e. direction
and speed of sorting out of the early endosome, fusion with the
recycling endosome, and exit from this compartment.
The mammalian glucose transporter GLUT4 is an integral membrane protein
specific to muscle and fat cells that undergoes both constitutive
recycling (2) and insulin-regulated exocytosis (3). The importance of
this phenomenon is highlighted by evidence that GLUT4 externalization
is defective in the pathophysiological state of insulin resistance
underlying type 2 diabetes (4-6). Despite extensive work, the
intracellular donor compartments remain poorly defined as do the
effects of insulin on the route or the velocity of inter-compartmental
GLUT4 traffic. This paucity in knowledge is largely because of
shortcomings of biochemical approaches to isolate and characterize the
diverse intracellular compartments populated by GLUT4 and by the
limited intracellular space available for detailed immunolocalization
in primary fat and muscle tissue and in cultured adipocytes.
Here we used L6 myoblasts stably expressing GLUT4 bearing an
extracellular Myc epitope (GLUT4myc) to examine the time course and
route of GLUT4 intracellular transit. The subcellular distribution of
GLUT4myc in L6 muscle cells was previously characterized (7-9). Ninety
percent of this protein was sequestered intracellularly (9), more than
half of it in compartments that segregate from the constitutively
recycling isoform GLUT1 (8). Insulin mobilizes GLUT4myc to attain a new
steady state distribution where 30% is exposed at the cell surface
(9). This translocation occurred with a t1/2 of 3.5 min, resembling the rate of GLUT4 exocytosis in adipose cells (2, 10).
The movement of GLUT4myc to the surface of L6 myoblasts was prevented by expression of dominant negative mutants of phosphatidylinositol (PI)1 3-kinase and Akt/PKB
(11) and was sensitive to agents that prevent actin remodeling (7, 12,
13). Insulin-dependent translocation of GLUT4myc differed
from basal state recycling of GLUT4myc in its sensitivity to tetanus
toxin, suggesting that basal and insulin-stimulated GLUT4myc arrive at
the plasma membrane on distinct vesicles (14). Like the endogenous
GLUT4 of muscle and adipose cells, GLUT4myc also responds to other
stimuli such as hyperosmolarity (9) and dinitrophenol (15).
When partially detached from the substratum, L6 myoblasts round up and
thus offer the opportunity to discern with clarity the intracellular
compartments populated by GLUT4myc using fluorescence microscopy. Here
we take advantage of the exofacial exposure of the Myc epitope to
follow the journey of GLUT4myc during its recycling back to the cell
surface. After labeling with an anti-Myc antibody the transporter
summoned to the cell surface in response to insulin, we analyze its
temporal and spatial intracellular coordinates during its
internalization in the absence and presence of insulin. Strikingly, we
observed that insulin expedites GLUT4 transit into and out of the
recycling endosome. Dominant-negative mutants of PI 3-kinase or PKB
blocked the insulin-dependent acceleration of GLUT4myc
traffic. These results provide evidence for a previously unknown action
of insulin, i.e. to speed up inter-endosomal GLUT4 traffic.
This increase may be the basis for the acceleration of GLUT4 recycling
caused by the hormone.
Materials--
The following antibodies were obtained from
commercial sources: rabbit (A-14) and mouse (9E10) antibodies against
the c-Myc epitope (Santa Cruz Biotechnology, Santa Cruz, CA), mouse
antibodies against human transferrin receptor (TfR) (Zymed
Laboratories Inc., San Francisco, CA), fluorescein
isothiocyanate, Cy3, and horseradish peroxidase-coupled donkey
anti-mouse and anti-rabbit secondary antibodies (Bio/Can Scientific,
Mississauga, ON, Canada). 9E10 was also a generous gift of Dr. Mike
Moran. Rabbit antibodies against early endosome antigen 1 (EEA1) were a
gift of Drs. Heidi McBride and Marino Zerial (EMBL, Heidelberg,
Germany). TO-PRO3 and rhodamine-conjugated transferrin were obtained
from Molecular Probes (Eugene, OR). DNA encoding the extracellular
domain of CD25 and the transmembrane and cytoplasmic domains of furin
(16) was a generous gift from Dr. Juan Bonifacino (National Institutes of Health, Bethesda, MD). DNA encoding a dominant negative mutant of
the p85 Cells and Tissue Culture--
A subclone of the L6 rat skeletal
muscle cell line stably expressing GLUT4 with an exofacial Myc epitope
(L6-GLUT4myc) has been described previously (7-9, 11, 15, 17). For all
experimental conditions, cells were serum-deprived for 3 h before
treatments. Where indicated, L6-GLUT4myc myoblasts were transiently
transfected using the liposome-mediated Effectene reagent (Qiagen,
Mississauga, ON, Canada) according to the manufacturer's protocol.
Marker DNA (enhanced green fluorescent protein) was transfected
in a 1:4 ratio with construct DNA.
Cell Population Assay of GLUT4myc Recycling and
Endocytosis--
For recycling studies, L6 GLUT4myc myoblasts grown in
24-well tissue culture plates were incubated at 37 °C with anti-Myc antibody 9E10 (8 µg/ml) in the absence or presence of 100 nM insulin. At the indicated times, cells were washed with
ice-cold PBS, fixed with 3% formaldehyde in PBS at 4 °C for 20 min,
and permeabilized with 0.1% Triton X-100 at room temperature for 30 min. This was followed by incubation in PBS containing 5% goat serum
and reaction with horseradish peroxidase-conjugated donkey anti-mouse
IgG (1:1,000) at 4 °C for 1 h, washing six times with PBS, and
incubation with 1 ml/well o-phenylenediamine dihydrochloride
(0.4 mg/ml) for 20-30 min at room temperature. The reaction was
stopped by addition of 0.25 ml of 3 N HCl, and the optical
absorbance was measured at 492 nm. The total content of GLUT4myc was
calculated by permeabilizing the cells using 0.1% Triton X-100 before
incubation with 9E10 antibody, as reported earlier (9). The amount of
GLUT4myc label at each time point is expressed as the percent of the
total GLUT4myc (Fig. 1).
For endocytosis studies, L6-GLUT4myc myoblasts grown in 24-well tissue
culture plates were stimulated with 100 nM insulin at
37 °C for 30 min. Cells were then rinsed three times with ice-cold PBS and labeled with 9E10 (8 µg/ml) for 1 h at 4 °C in the
absence of insulin. Medium pre-warmed to 37 °C was added, and the
plates were incubated in the presence or absence of insulin for
indicated times. Where indicated, 100 nM wortmannin was
added during the 1-h incubation with 9E10 and maintained in 100 nM wortmannin throughout the internalization period. At the
indicated times cells were placed on ice, washed once with ice-cold
PBS, and fixed briefly with 3% formaldehyde in PBS at 4 °C for 10 min. Cells were then incubated with horseradish peroxidase-conjugated
donkey anti-mouse IgG (1:1,000) at 4 °C for 1 h, followed by
washes and reaction with o-phenylenediamine dihydrochloride
as described above for GLUT4myc recycling. Cell surface levels of
GLUT4myc are expressed as a percentage of the amount of cell surface
GLUT4myc on control cells at 0 min of internalization.
Immunofluorescence in Rounded-up Myoblasts--
L6-GLUT4myc
myoblasts were detached from the substratum using nominally
Ca2+- and Mg2+-free PBS. This condition was
used instead of trypsin to preserve the GLUT4myc and insulin receptor
molecules on the cell surface. Rounded-up (semi-attached) myoblasts
offer the opportunity to study topological distribution of
intracellular compartments by fluorescence confocal microscopy.
Flattened myoblasts (and other cell types) afford considerably less
resolution by this approach, especially in differentiating
surface-bound from intracellular epitopes. Total removal of
Ca2+ from the extracellular milieu is reported to be
inconsequential to GLUT4 translocation (18). After resuspending in
HEPES-buffered RPMI, myoblasts were allowed to settle on coverslips for
10 min while treating them with or without 100 nM insulin
at 37 °C. To determine the overall cellular localization of GLUT4myc
in these rounded-up myoblasts, the cells were immediately fixed in
ice-cold 4% formaldehyde in PBS containing Ca2+ and
Mg2+ for 20 min. The cells were then permeabilized in 0.1%
Triton X-100 for 30 min and blocked for 20 min with 5% goat serum.
GLUT4 was detected using anti-Myc polyclonal antibody A-14 (1.33 µg/ml), and the TfR-containing compartment was detected using
monoclonal anti-TfR antibody (1:1,000). These antibodies were added to
the cells for 1 h followed by secondary antibodies (1:250) along
with the DNA stain TO-PRO3 (2 µM). Coverslips were
mounted on glass slides and imaged using a Zeiss Axiovert 100M laser
scanning confocal microscope 510.
To determine endocytic transit of cell surface-labeled GLUT4myc,
rounded-up myoblasts resuspended in HEPES-buffered RPMI were allowed to
settle (semi-attach) on coverslips for 10 min at 37 °C in the
presence or absence of 100 nM insulin. The coverslips were
transferred to 4 °C to halt all vesicular traffic and then incubated
in the absence of insulin for 1 h at 4 °C with Hepes-buffered RPMI medium containing anti-Myc antibodies (1.33 µg/ml
polyclonal A-14 or 4 µg/ml of monoclonal 9E10 as indicated).
Coverslips were then washed, maintained at 37 °C in the absence or
presence of 100 nM insulin for 10 or 20 min, and then
immersed in ice-cold 4% formaldehyde in PBS containing
Ca2+ and Mg2+ for 20 min followed by quenching
with ice-cold 50 mM NH4Cl for 10 min. The cells
were then permeabilized in 0.1% Triton X-100 for 30 min at room
temperature and blocked for 20 min with 5% goat serum. Primary
antibodies against TfR (1:1,000) or EEA1 (1:250) were added to the
cells for 1 h followed by fluorophore-conjugated secondary
antibodies (1:250) along with the DNA stain TO-PRO3 (2 µM). Coverslips were mounted on glass slides and imaged
using a Zeiss Axiovert 100M laser scanning confocal microscope 510. Secondary antibodies used in this study showed no detectable labeling of L6-GLUT4myc cells when incubated in the absence of primary antibodies. Gain settings for the photomultiplier tube were adjusted for each experiment to bring all images within the linear range of the
detector. Images of Cy5 or TO-PRO3 labeling were given a false blue
color to aid in visualization. More than 100 cells were observed per
condition per experiment, and representative images of each condition
are shown. The extent of colocalization between GLUT4myc and EEA1 or
TfR signals was quantified using NIH Image (NIH, Bethesda, MD) and
Adobe Photoshop (Adobe Systems Inc., San Jose, CA). The yellow signal
generated by overlap between the pair of fluors was separated from the
remaining image using the Select Color Range option in Adobe Photoshop.
For panels i-n in Fig. 8 the green (green
fluorescent protein) channel of the RGB Photoshop image was
replaced with the blue (TfR) channel for purposes of quantitation. The
intensity of the yellow signal selected in this way was then expressed
as a percentage of the intensity of the entire GLUT4myc signal.
To determine endocytic transit of rhodamine-conjugated transferrin,
rounded-up myoblasts resuspended in HEPES-buffered RPMI were allowed to
settle (semi-attach) on coverslips while being loaded for 10 min at
37 °C with 100 µg/ml of rhodamine-transferrin. Coverslips were
transferred to HEPES-buffered RPMI devoid of rhodamine-transferrin and
maintained at 37 °C in the absence or presence of 100 nM
insulin for 10 or 20 min, then placed directly in ice-cold 4%
formaldehyde in PBS containing Ca2+ and Mg2+
for 20 min followed by quenching with 50 mM
NH4Cl for 10 min. The cells were then permeabilized in
0.1% Triton X-100 for 30 min at room temperature and blocked for 20 min with 5% goat serum. Primary antibody against TfR (1:1,000) was
added to the cells for 1 h followed by secondary goat anti-mouse
alexa 488 antibody (1:500) along with the DNA stain TO-PRO3 (2 µM). Coverslips were mounted on glass slides and imaged
using a Zeiss Axiovert 100M laser scanning confocal microscope 510.
Immunological Detection of Insulin-dependent
Signals--
L6-GLUT4myc myoblasts grown to confluency in six-well
tissue culture plates were serum-starved for 4 h, then incubated
without or with 100 nM insulin at 37 °C for 30 min. Some
wells were then washed with PBS three times, incubated at 4 °C for
1 h in the absence of insulin, washed three times again, and
analyzed at this point; the other half was incubated for an additional
10 min at 37 °C before analysis. All cells were then rinsed twice with PBS containing 1 mM Na3VO4 and
lysed with 300 µl/well 2× SDS-polyacrylamide gel electrophoresis
sample buffer containing 5 µM E-64, 1 µM
leupeptin, 2.5 µM pepstatin, 1 mM
Na3VO4, 0.1 mM phenylmethylsulfonyl
fluoride, and 100 nM okadaic acid. After scraping the
lysates, they were passed 5 times through a 25-guage syringe and
incubated at 65 °C for 15 min. Once cooled to 20 °C, the lysates
were resolved by SDS-polyacrylamide gel electrophoresis, transferred to
polyvinylidine difluoride membrane, and immunoblotted with antibodies
against phosphotyrosine (PY99, Santa Cruz Biotechnology) or
phosphothreonine 308 of PKB (phospho-Akt (Thr-308), New England Biolabs, Mississauga, ON).
Rates of Recycling of GLUT4myc in the Absence and Presence of
Insulin--
L6-GLUT4myc myoblasts were incubated in the absence or
presence of insulin, and any GLUT4myc molecule arriving at the cell surface was labeled with anti-Myc antibody 9E10 during the incubation. In the absence of insulin, half-maximal recycling occurred after 2 h, whereas insulin sharply increased the rate of GLUT4myc recycling, reducing the half-time to about 40 min (Fig.
1). This result confirms that GLUT4myc
behaves as reported for the endogenous GLUT4 in adipose cells (2, 19).
Moreover, the rate of recycling of GLUT4myc is similar to that
determined for a chimeric protein encoding the exofacial portion of the
TfR and the cytosolic tail of the insulin-regulated aminopeptidase vpTR
(or IRAP) (20, 21). Fig. 1 also shows that virtually all the cellular
GLUT4myc molecules were available for surface labeling within 6 h,
establishing that the antibody-labeled transporter is able to recycle
without undergoing degradation. Insulin accelerated this recycling so that all GLUT4myc molecules were labeled within 3 h.
Rate of Disappearance of GLUT4myc from the Cell Surface--
To
measure the rate of removal of GLUT4myc from the cell surface,
L6-GLUT4myc myoblasts were stimulated with insulin for 30 min to expose
GLUT4myc at the cell surface. This treatment consistently increases
cell-surface GLUT4myc by 2-3-fold in these cells (7, 8, 11). Such an
increase is consistent with the change observed in isolated skeletal
muscles (22, 23). The exofacially exposed Myc epitope was then labeled
at 4 °C with anti-Myc antibody for 1 h and then allowed to
internalize upon warming to 37 °C. Insulin and/or wortmannin were
added during the internalization period to examine their effects on
disappearance of GLUT4myc from the cell surface. Fig.
2 shows that labeled GLUT4myc disappeared
from the cell surface with a t1/2 of 3 min for all
treatments, fitting a one-phase exponential decay curve
(r2 values: control, 0.970; insulin, 0.928;
wortmannin, 0.999; insulin plus wortmannin, 0.999). Tukey's pairwise
analysis of variance of all values at each time point indicated that
only the 30-min insulin re-addition and 30-min insulin re-addition plus
wortmannin points were significantly different from one another
(p < 0.05). These results suggest that there is no
evident effect of insulin on the initial rate of removal of GLUT4myc
from the cell surface. The separation of the insulin-treated curve from
the curves in other conditions at longer time points is likely the
result of the enhanced recycling of labeled transporters back to the
cell surface.
Insulin Signaling Is Significantly Reduced after Insulin Removal
and Incubation for 1 h at 4 °C--
The lack of effect of
insulin on GLUT4myc removal from the cell surface raised the question
of whether insulin signals are maintained during incubation of
myoblasts for 1 h at 4 °C so that re-addition of insulin to the
cells after this time period would not have any further input. To
address this possibility, myoblast monolayers were incubated as
described in Fig. 1 but without the addition of primary antibody during
the 1-h incubation at 4 °C. The cells were then lysed in SDS sample
buffer, resolved by SDS-polyacrylamide gel electrophoresis, and
immunoblotted to probe for phosphotyrosine-containing proteins and for
phosphothreonine 308 of PKB. The results shown in Fig.
3 indicate that
insulin-dependent increases in a 175-kDa phosphotyrosine
protein (likely IRS-1) and phosphorylated (on threonine 308) PKB (the
site phosphorylated by phosphoinositide-dependent protein
kinase-1) had returned to near basal levels after 1 h of
incubating cells in the absence of insulin at 4 °C. These results indicate that during the internalization period, any effects of prior
insulin addition are not preserved, and therefore subsequent addition
of insulin represents re-stimulation of the cells with the hormone.
Insulin Causes Relocation of GLUT4myc in Rounded-up
Myoblasts--
The increase in GLUT4myc recycling without reduction in
GLUT4myc removal from the cell surface suggests that insulin
stimulation increases the rate of return of GLUT4myc to the cell
surface. It is therefore important to examine the mechanism leading to increased recycling in space and time. For this purpose, we were required to maximize our ability to discern the location of GLUT4myc vis à vis known organellar markers. When spread out on
substratum, the cytosol of myoblasts (as well as fibroblasts) is
distributed very thinly over a large area, making it difficult to
distinguish juxtamembrane localization of immunofluorescent signals
from more internal signals. To overcome this problem we lifted
L6-GLUT4myc myoblasts off tissue culture flasks by incubating them in
the absence of Ca2+ and Mg2+ for ~20 min.
Once detached, myoblasts were allowed to settle onto coverslips for 10 min in the absence and presence of insulin, fixed, and
immunocytochemically labeled for GLUT4myc and TfR as well as stained
for DNA with TO-PRO3 (Fig. 4). In the
absence of insulin, a large fraction of the GLUT4myc label was
intracellular, with a loose perinuclear pattern. At this steady state
distribution, a significant portion of intracellular GLUT4myc escaped
colocalization with the TfR-containing compartment. Insulin addition
caused translocation of a fraction of the GLUT4myc signal to the cell
periphery. On the other hand, virtually all of the TfR was detected
intracellularly in a compact region about the nucleus in the absence
and presence of insulin, with no discernible changes caused by the
presence of the hormone. DNA labeling was included to add perspective
and emphasize the perinuclear localization of the TfR-containing
compartment. Fig. 4 illustrates the ability to determine intracellular
and surface GLUT4myc in rounded-up myoblasts, and that GLUT4myc
responds to insulin in rounded-up L6 myoblasts by translocating to the cell surface.
GLUT4myc Travels through the Early Endosome to the Recycling
Endosome--
Morphologically, different endosomes are defined by the
presence of marker proteins. EEA1 is a putative tethering protein that
helps to bring vesicles in close proximity with the early endosome and
is found solely on early endosomes (24). Numerous proteins undergo
constitutive recycling between the plasma membrane and the recycling
endosome. The TfR is responsible for iron entry into the cell via
binding to transferrin and is constitutively recycled back to the cell
surface (25). The relative abundance of TfR on the plasma membrane and
in the recycling endosome varies among cell types. Greater than 90% of
the TfR resides in the recycling endosome in L6
myoblasts,2 making it a
suitable marker for this compartment.
To follow the transit of GLUT4myc through the early endosome and
recycling endosome, surface GLUT4myc labeled with anti-Myc antibodies
in intact myoblasts was allowed to internalize at 37 °C for
different times up to 20 min. At each time point studied, the
localization of internalized GLUT4myc was compared with the steady
state distribution of endosomal markers. Fig.
5a shows the localization of
labeled GLUT4myc and EEA1 at the onset of rewarming. Two min after
initiation of internalization, some GLUT4myc could be detected in a
compartment positive for EEA1 staining (Fig. 5b) and
remained in this compartment for at least 5 min (Fig. 5c).
At 10 min, there was no detectable labeled GLUT4myc in the perinuclear,
TfR-positive compartment (Fig. 5d), but by 15 min (Fig.
5e) GLUT4myc began to collect there, and by 20 min (Fig.
5f) a large portion of the labeled GLUT4myc overlapped with TfR. This distribution remained for up to 30 min (longer times could
not be analyzed because of flattening of the myoblasts).
Insulin Re-addition Accelerates the Transit of GLUT4 through the
Endosomal System--
GLUT4myc was allowed to internalize and chased
in the absence or presence of re-added insulin. The hormone did not
appear to affect the rate of appearance of surface-labeled GLUT4myc in the EEA1-positive compartment (Fig. 6,
a-d). Approximately 10% of the GLUT4myc was found in the
EEA1-positive compartment (Fig. 6, a-d) for up to 8 min
(results not shown). Insulin did not affect the staining patterns of
EEA1 or TfR (steady state distribution). In unstimulated cells after a
10-min chase, 10.2% of surface-labeled GLUT4myc was detected in the
recycling endosome (Fig. 6e), and by 20 min this
colocalization increased to 30.1% (Fig. 6f). In contrast,
in the continued presence of insulin, 36.9% of labeled GLUT4myc was
already present in the TfR-positive compartment at 10 min after
initiation of internalization (Fig. 6g). Moreover, by 20 min, only 9.9% of the labeled GLUT4myc internalized in the continued presence of insulin was detectable in the
TfR-containing endosomes (Fig. 6h).
To begin to explore the transit of other recycling proteins, we
investigated the routing of internalized rhodamine-transferrin (Fig.
7). For these experiments,
rhodamine-transferrin was provided to the cells during the 10 min of
attachment to the coverslip at 37 °C to allow enough label to enter
the cells. After this 10-min pre-loading period, external
rhodamine-transferrin was removed, and the localization of the
intracellular ligand was chased in space and time. At this point, most
of the internalized rhodamine-transferrin was observed in a layer below
the plasma membrane, presumably in early endosomes (Fig.
7a). After a subsequent 10 min of internalization (for a
total of 20 min from the beginning of transferrin loading), significant
rhodamine-transferrin was detected in the perinuclear compartment
characterized by the bulk of the TfR, i.e. the recycling
endosome (Fig. 7b). Importantly, the presence of insulin
during the internalization of rhodamine-transferrin did not appear to
alter the arrival of this cargo molecule at the recycling endosome
(Fig. 7c). Upon a further 10 min of internalization (for a
total of 30 min), the internalized rhodamine-transferrin was absent
from this compartment either in the presence or absence of insulin (not
shown). The label could be found in the cytosol of unstimulated cells
but had largely exited all insulin-stimulated cells. These results are
consistent with an increase in transferrin recycling caused by the
hormone, leading to rhodamine-transferrin re-externalization. An
in-depth study of the coincident transit of GLUT4myc and
rhodamine-transferrin is called for through future research. At
present, the absolute times of transit of each molecule are not
directly comparable because of the need to load with
rhodamine-transferrin for 10 min at 37 °C to obtain sufficient
label. Nonetheless, the results of Figs. 6 and 7 suggest that insulin
differentially affects the inter-endosomal transit of these two
molecules. Insulin accelerates the arrival of surface-labeled GLUT4myc
at the recycling endosome but not that of rhodamine-transferrin.
Acceleration of GLUT4myc Traffic because of Insulin Is Dependent on
PI 3-Kinase and PKB--
PI 3-kinase activity is required for
insulin-dependent translocation of GLUT4 to the plasma
membrane (26-30), but the exact steps regulated by the enzyme are not
known. To explore the role of PI 3-kinase in GLUT4 endocytic traffic,
surface-labeled GLUT4myc was chased during its internalization for 10 (Fig. 8, a-d) or 20 (Fig. 8,
e-h) min in the absence (Fig. 8, a,
b, e, and f) or presence (Fig. 8,
c, d, g, and h) of insulin,
without (Fig. 8, a, c, e, and
g) or with (Fig. 8, b, d,
f, and h) cellular pretreatment with the PI
3-kinase inhibitor LY294002. In the absence of insulin, LY294002
slightly slowed the time course of movement of labeled GLUT4myc through
the recycling endosome (compare Fig. 8, a with b,
e with f). In contrast, in insulin-stimulated
cells LY294002 prevented the accelerated movement of GLUT4myc through
this compartment (compare Fig. 8, c with d,
g with h). In fact, the time course of
colocalization of labeled GLUT4myc with TfR was similar for control
unstimulated cells as for LY294002-pretreated, insulin-stimulated cells.
To further demonstrate that PI 3-kinase is involved in
insulin-dependent acceleration of inter-endosomal traffic
and to test the role of PKB/Akt in this process, dominant-negative DNA
constructs of the two enzymes were transiently transfected into
L6-GLUT4myc cells. A construct coding for the p85 subunit of PI
3-kinase lacking the intervening SH2 domain that binds the catalytic
p110 subunit has been shown to override the insulin-stimulated
activation of endogenous PI 3-kinase (31) and to inhibit
insulin-induced arrival of GLUT4myc to the cell surface (11, 32). We
have shown that a construct encoding PKB with three point mutations
(K179A, T308A, and S473A) named AAA-PKB overrides the
insulin-stimulated activation of co-transfected PKB Internalized GLUT4myc Does Not Travel to the Trans-Golgi Network
(TGN)--
Because GLUT4myc travels through the recycling endosome and
retrograde transport of some proteins takes place from the recycling endosome to the TGN (33), it was conceivable that internalized, surface-labeled GLUT4myc might cycle through the TGN. Indeed, some
models of GLUT4 segregation at steady state have suggested the presence
of some GLUT4 in the TGN. To address whether during its endocytosis
GLUT4 reaches the TGN, L6-GLUT4myc cells were transiently transfected
with a construct encoding the transmembrane, and cytosolic domains of
the endopeptidase furin, a TGN-resident protein, fused to the
extracellular domain of the high affinity interleukin-2 receptor (CD25)
as an epitope (16). After allowing surface-labeled GLUT4myc in
transfected myoblasts to internalize, the cells were labeled with
anti-CD25 antibody to reveal the TGN and TO-PRO3 to reveal the
nucleus. Internalized, surface-labeled GLUT4myc did not
colocalize appreciably with furin-CD25 staining at either 0 (Fig.
9a), 10 (Fig. 9b),
or 20 (Fig. 9c) min of endocytosis. Instead, within the
limits of our detection system, surface-labeled GLUT4myc appeared in a
furin-negative perinuclear compartment after internalization. This site
is likely the TfR-positive compartment seen in Figs. 4-6, which can be
distinctively resolved from the furin-containing compartment (Fig.
9d).
Biochemical and morphological approaches have been used to
date in an effort to characterize the endomembranes populated by GLUT4.
Gradient centrifugation of adipose cells has revealed at least two if
not three distinct intracellular compartments containing GLUT4 (34, 35)
as have mathematical models built from measurements of steady state
distributions of GLUT4 (36, 37). Moreover, the soluble
N-ethylmaleimide-sensitive factor attachment protein receptor proteins (SNAREs) vesicle-associated membrane protein-2, syntaxin 4, and synaptosome-associated protein of 23 kDa are required for about 50% of the insulin-induced GLUT4 translocation in muscle and
fat cells (see Ref. 38), suggesting that insulin draws GLUT4 from two
pools distinguishable by their complement of fusogens. Consistent with
this scenario, oxidative ablation of transferrin-containing compartments by transferrin-coupled horseradish peroxidase obliterates 30-50% of the intracellular GLUT4 of 3T3-L1 adipocytes (39, 40),
indicating that the recycling endosome is one of the compartments populated by GLUT4. Until now there had been no information on whether
insulin regulates the traffic through intracellular compartments in
either muscle or fat cells. Answering this question is key to our
understanding of GLUT4 availability for translocation.
For this study we selected L6 myoblasts stably expressing GLUT4 tagged
at its first exofacial loop with an Myc epitope. We have previously
shown that GLUT4myc is effectively sequestered intracellularly in L6
myoblasts and myotubes such that at steady state only 10% of the
transporter is found at the cell surface (9). In its intracellular
location, GLUT4myc largely segregates away from GLUT1 or GLUT3 but
co-segregates with IRAP, based on immunoadsorption of membranes with
antibodies to each of these antigens (8). Moreover, GLUT4myc responds
to insulin by mobilizing to the plasma membrane of L6 myotubes and in
this respect mimics quantitatively the movement of endogenous GLUT4
(7). Additional studies confirm that GLUT4myc is a reliable marker of
GLUT4 traffic and, in response to insulin, its mobilization to the cell
surface requires the SNARE VAMP2 and input from PKB/Akt (11, 14). In
the present study we further characterize the recycling rate of this
molecule in L6 myoblasts and confirm that insulin increases its
recycling rate to the cell surface (Fig. 1). Moreover, we show by
confocal microscopy that GLUT4myc is concentrated in a perinuclear
compartment and that it markedly increases at the cell surface upon
insulin stimulation in rounded-up myoblasts (Fig. 4). This behavior is
highly reminiscent of the sequestration and movement of GLUT4 in rat
and mouse adipose cells and suggests that rounded-up L6 myoblasts
expressing GLUT4myc constitute a useful and reliable cell system to
study spatial/temporal coordinates of GLUT4 traffic in response to
insulin and other stimuli.
In the present study we measured the rates of GLUT4myc
recycling and disappearance of GLUT4myc from the cell surface and
followed the localization of the transporter once internalized in L6
myoblasts. Insulin markedly increased the rate of GLUT4myc recycling
(Fig. 1) without altering the rate of GLUT4myc removal from the cell surface within 10 min of initiation of endocytosis (Fig. 2). Given that
insulin markedly increases GLUT4myc recycling back to the cell
surface, this observation suggests that the primary effect of insulin
in muscle cells is to promote the externalization of GLUT4myc. Studies
with rat primary adipocytes have yielded conflicting results, some
failing and others detecting a small effect of insulin on the rate of
removal of GLUT4 from the cell surface (2, 19). There is evidence for a
small reduction in the rate of GLUT4 internalization caused by insulin,
detected by either photolabeling of surface transporters in 3T3-L1
adipocytes followed by immunoprecipitation (41) or by proteolytic
cleavage of an exofacially exposed site in isolated rat adipocytes
followed by subcellular fractionation (42). In all cases, however, by
far the major effect of insulin was a stimulation of the exocytic arm
of its recycling (2, 19, 41, 42). In the present study GLUT4myc
internalization was measured by a simpler procedure not requiring
either immunoprecipitation or subcellular fractionation, techniques
that have complications of incomplete recoveries. It is not clear
whether the use of different techniques or a cell-type specificity are
responsible for the lack of evidence for an
insulin-dependent reduction in GLUT4myc removal from the
cell surface in L6 myoblasts. Consistent with the present results,
insulin did not alter the rate of removal from the cell surface of IRAP
(21) or of a chimera expressing the cytosolic IRAP region and the
extracellular TfR region (20) in 3T3-L1 adipocytes.
The stimulation of the externalization of GLUT4myc could conceivably
involve events of intracellular sorting/transit as well as events of
mobilization of vesicles directly to the plasma membrane. To begin to
explore these possible phenomena, we resorted to a spatial and temporal
analysis of the localization of surface-labeled GLUT4myc. For these
studies, insulin was given to cells for 10 min to summon GLUT4myc to
the cell surface, where it was labeled with antibody at 4 °C, and
then its intracellular transit was examined in space and time under
conditions where insulin signals had waned or with re-added insulin.
Once antibody-labeled GLUT4myc was internalized in the absence of
insulin, the transporter was chased and found to be present in a
compartment marked by the early endosomal marker EEA1. The presence of
insulin did not appear to alter the time course of appearance of
labeled-GLUT4myc in this organelle.
Within 10 min of initiation of its internalization, some GLUT4myc
reached the TfR-containing compartment, but a more significant accumulation was noted at 20 min. Strikingly, insulin cut by half the
time required for labeled-GLUT4myc to accumulate in the TfR-containing compartment. Moreover, by 20 min, GLUT4myc internalized in the presence
of insulin had exited from the recycling endosome. We interpret these
results to reveal a novel, insulin-induced acceleration of GLUT4myc
through the endosomal system. In contrast, internalized rhodamine-transferrin was detected in this compartment 20 min after
initiation of loading with this ligand, whether in the absence or
presence of insulin. Importantly, the PI 3-kinase inhibitor LY294002
and a dominant negative form of the p85 Although finding surface-labeled GLUT4myc in the recycling endosome was
not surprising, the observed effect of insulin on the inter-endosomal
traffic of GLUT4 was unexpected. At steady state, intracellular
GLUT4myc was found both in the recycling endosomes and in punctate
structures within the cytosol (Fig. 4). Immunoadsorption of
GLUT4-containing bodies results in segregation of over half of GLUT4myc
away from GLUT1 (8), and arrival of basal and insulin-stimulated
GLUT4myc vesicles are differentiated by their sensitivity to tetanus
toxin (9, 14). These results suggest that, as in rodent adipocytes, a
portion of GLUT4 segregates from the recycling compartment. However,
the site of such segregation and the origin of the specialized
segregated compartment were unknown. The findings reported here lead us
to propose a revised model of intracellular GLUT4 traffic and its
regulation by insulin as presented in Fig.
10. In this model, internalized GLUT4
travels through the early endosome defined by the presence of EEA1 and progresses to the recycling endosome defined by TfR. Insulin
accelerates GLUT4 arrival at the recycling endosome. Our results also
suggest that insulin accelerates the exit of GLUT4 from this
compartment since the residence time of labeled GLUT4myc in the
TfR-positive endosome was >10 min in the absence of insulin but <10
min in the presence of the hormone. The above results suggest that
insulin input is required for at least two distinct functions, movement of GLUT4 into the recycling endosome (Fig. 10) and budding out of the
recycling endosome. We propose that, from the recycling endosome
GLUT4myc would travel to the cell surface, possibly via generation of
specialized exocytic vesicles. Our model also proposes that sorting of
GLUT4 occurs in the recycling endosome but does not rule out that a
portion of the exocytic vesicle pool may form directly from the early
endosome, since there was always a fraction of the internalized
GLUT4myc that did not colocalize with TfR at either 10 or 20 min after
internalization. That the TGN does not appear to be involved in
insulin-dependent GLUT4 traffic is borne out by previous
studies showing that brefeldin A does not prevent
insulin-dependent GLUT4 exocytosis (45-49) with one
exception (50). Yet GTP
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit of PI 3-kinase (
p85
) was a generous gift from
Dr. Julian Downward (Imperial Cancer Research Fund, UK). Dominant
negative PKB (AAA-PKB) was a generous gift of Dr. James Woodgett
(Ontario Cancer Institute, Toronto, Canada).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (13K):
[in a new window]
Fig. 1.
Insulin increases the rate of recycling of
GLUT4myc in myoblasts. L6-GLUT4myc myoblasts were incubated with
anti-Myc (9E10) antibody at 37 °C in the presence (
) or absence
(
) of 100 nM insulin. At the indicated times, cells were
fixed and permeabilized to determine the amount of GLUT4myc protein
bound by the 9E10 antibody using the cell population-based
enzyme-linked absorbance assay described under "Experimental
Procedures." Total content of GLUT4myc was calculated by
permeabilizing the cells before incubation with 9E10 antibody. The
amount of GLUT4myc label at each time point is expressed as the percent
of the total GLUT4myc. Data are the mean ± S.E. of at least three
experiments.

View larger version (14K):
[in a new window]
Fig. 2.
Insulin does not affect the rate of GLUT4myc
retrieval from the cell surface. L6-GLUT4myc myoblasts were
stimulated with insulin, then surface GLUT4myc was labeled with
anti-Myc antibody at 4 °C in the absence of insulin. After three
washes, the disappearance of GLUT4myc from the plasma membrane was
measured in untreated (
), insulin re-stimulated (
),
wortmannin-treated (
), and insulin- and wortmannin-treated (
)
cells using the cell population assay for GLUT4myc endocytosis
described under "Experimental Procedures." The absorbance value of
control cells at t = 0 was defined as 100%, and all
other values were normalized to this value. The value at 30 min of
insulin treatment is significantly different from the 30-min value for
insulin plus wortmannin (p < 0.05, Tukey's analysis
of variance). No other values are significantly different from any
other in the same time group. Data are the mean ± S.E. of at
least three experiments.

View larger version (14K):
[in a new window]
Fig. 3.
Insulin removal during incubation at 4 °C
results in loss of intracellular signaling. Levels of general
tyrosine phosphorylation (pY, top panel) and PKB
threonine 308 phosphorylation (bottom panel) were detected
by immunoblotting in unstimulated cells (lane 1), cells
pre-stimulated with insulin (ins., lane 2),
insulin pre-stimulated cells washed and maintained at 4 °C for
1 h in the absence of insulin (lane 3), and insulin
pre-stimulated cells, washed and maintained at 4 °C for 1 h
followed by 10 min at 37 °C in the absence of insulin (lane
4). The lower set of bands in the top blot likely represent
IRS-1 based on molecular weight (~175 kDa).

View larger version (49K):
[in a new window]
Fig. 4.
Insulin-induced relocalization of GLUT4myc
from a perinuclear compartment to the cell surface in rounded-up
myoblasts. L6-GLUT4myc myoblasts were rounded-up and incubated for
10 min in the absence or presence of 100 nM insulin
(con and ins, respectively) at 37 °C during
the re-attachment period. These rounded-up cells were then fixed,
permeabilized, and immunostained to detect GLUT4myc (red),
TfR (green) and DNA (blue) as outlined under
"Experimental Procedures." The cells were examined by confocal
fluorescence microscopy. Shown are representative cells from one of
three independent experiments. Three cells (one high magnification, two
low magnification) are shown for each condition. The scale
bar represents 10 µm in the larger images.

View larger version (42K):
[in a new window]
Fig. 5.
Internalized GLUT4myc travels through the
early and recycling endosomes. L6-GLUT4myc myoblasts were
rounded-up and incubated for 10 min in the presence of 100 nM insulin at 37 °C during the re-attachment period. The
cells were then chilled, rinsed, and incubated for 1 h with
anti-Myc antibody in the absence of insulin as described under
"Experimental Procedures." After the wash steps, internalization
was allowed by switching the cells to 37 °C for the indicated time
periods. At each time point, the cells were fixed and stained with
secondary antibody along with antibodies to the indicated markers.
Shown are confocal fluorescence microscopy images of surface-labeled
GLUT4myc after 0 (a), 2 (b), 5 (c), 10 (d), 15 (e), and 20 (f) min of the
beginning of internalization at 37 °C in these rounded-up myoblasts.
Red staining is GLUT4myc, blue staining is DNA,
green staining is EEA1 (a-c) or TfR
(d-f). Areas outlined by white boxes
(a-c) are expanded 4× in insets. Filled
arrowheads indicate areas of colocalization (yellow),
whereas open arrowheads highlight areas of no
colocalization. The scale bar represents 10 µm. Shown are
representative cells from one of three independent experiments.

View larger version (54K):
[in a new window]
Fig. 6.
Effect of insulin re-addition on
inter-endosomal GLUT4 traffic. L6-GLUT4myc myoblasts were
rounded-up and incubated for 10 min in the presence of 100 nM insulin at 37 °C during the re-attachment period. The
cells were then chilled, rinsed, and incubated for 1 h with
anti-Myc antibody in the absence of insulin as described under
"Experimental Procedures." After the wash steps, internalization
was allowed by switching the cells to 37 °C without or with insulin
re-addition for the indicated time periods. At each time point, the
cells were fixed and stained with secondary antibody along with
antibodies to the indicated markers. Shown are confocal fluorescence
microscopy images of surface-labeled GLUT4myc after 2 (a and
c), 5 (b and d), 10 (e and
g), and 20 (f and h) min of
endocytosis in the absence (a, b, e,
and f) or presence (c, d,
g, and h) of 100 nM re-added insulin
(ins) in rounded-up myoblasts. Red staining is
GLUT4myc, blue staining is DNA, green staining is
EEA1 (a, b, c, and d) or
TfR (e, f, g, and h).
Filled arrowheads indicate areas of colocalization
(yellow) between GLUT4myc and EEA1 or TfR, whereas
open arrowheads highlight TfR staining not colocalized with
GLUT4myc. The scale bar represents 10 µm in the more
magnified images. Shown are representative cells from one of six
independent experiments. Three cells (one high magnification, two low
magnification) are shown for each condition. Degrees of overlap
(mean ± S.E.) calculated for any given condition using NIH Image
and Adobe Photoshop are expressed as the percentage of colocalization
out of the total GLUT4myc (red) signal and are indicated
below each panel (see "Experimental Procedures").

View larger version (35K):
[in a new window]
Fig. 7.
Effect of insulin on inter-endosomal transit
of transferrin. L6-GLUT4myc myoblasts were rounded-up and
incubated for 10 min with rhodamine-transferrin at 37 °C during the
re-attachment period. Internalization was allowed for 10 additional
minutes (see "Experimental Procedures"). The cells were then fixed,
permeabilized, and incubated with antibody to the TfR, followed by a
fluorescein isothiocyanate-conjugated secondary antibody. Shown are
confocal fluorescence microscopy images of rounded-up myoblasts
pre-loaded with rhodamine-transferrin, analyzed immediately upon
termination of the 10 min of loading (a) or a subsequent 10 min internalization (for a total of 20 min) (b and
c) in the absence (b) or presence (c)
of 100 nM insulin (con and ins,
respectively). Red staining is rhodamine-transferrin,
blue staining is DNA, green staining is TfR. The
scale bar represents 10 µm. Shown are representative cells
from one of four independent experiments. The degrees of overlap
(mean ± S.E.) calculated for any given condition, using NIH Image
and Adobe Photoshop, are expressed as the percentage of colocalization
out of the total rhodamine-transferrin (red) signal and are
indicated below each panel (see "Experimental Procedures").

View larger version (58K):
[in a new window]
Fig. 8.
Acceleration of inter-endosomal traffic by
insulin re-addition is dependent on PI 3-kinase and PKB.
L6-GLUT4myc myoblasts transfected to express dominant negative p85 or
AAA-PKB were rounded-up and incubated for 10 min in the presence of 100 nM insulin at 37 °C during the re-attachment period. The
cells were then chilled, rinsed, and incubated for 1 h with
anti-Myc antibody in the absence of insulin as described under
"Experimental Procedures." After the wash steps, internalization
was allowed by switching the cells to 37 °C for the indicated time
periods in the absence or presence or re-added insulin. At each time
point, the cells were fixed and stained with secondary antibody along
with antibodies to the indicated markers. Shown are confocal
fluorescence images of surface-labeled GLUT4myc (red) in
relation to whole-cell TfR (green in a-h,
blue in i-n) after a 10 (a-d)- or 20 (e-n)-min endocytosis in the absence (a,
b, e, f, i, k,
and m) or presence (c, d,
g, h, j, l, and
n) of 100 nM re-added insulin, as indicated
(con and ins, respectively). Untransfected cells
were treated with Me2SO (a, c,
e, and g) or 25 µM LY294002
(LY, b, d, f, and
h) as indicated. The remaining panels represent cells
transiently transfected with empty vector (i and
j),
p85
(k and l), or AAA-PKB
(m and n). Transfected cells were identified by
the presence of cotransfected enhanced green fluorescent protein shown
in panels i-n (green). The filled
arrowheads indicate areas of colocalization (yellow for
a-h, purple for i-n) between
GLUT4myc and TfR, whereas the open arrowheads point out TfR
not colocalized with GLUT4myc. The scale bar represents 10 µm in the more magnified images. Shown are representative cells from
one of three independent experiments. Three cells (one large, two
small) are shown for each condition. Degrees of overlap (± S.E.)
calculated for any given condition, using NIH Image and Adobe
Photoshop, are expressed as the percentage of colocalization out of the
total GLUT4myc (red) signal and are indicated below each
panel (see "Experimental Procedures").
(11) and
PKB
3 and also inhibits
insulin-dependent exocytosis of GLUT4myc in L6 myoblasts
(11). Transfection of empty pcDNA3 vector had no effect on either
the unstimulated arrival of labeled GLUT4myc to the recycling endosome
marked by the TfR (Fig. 8i) or the insulin-stimulated movement of labeled GLUT4myc through this compartment (Fig.
8j) (images were taken 20 min after initiation of
internalization). Although neither
p85
nor AAA-PKB affected the
arrival of GLUT4myc to the TfR-containing recycling endosome in
unstimulated cells (Fig. 8, k and m,
respectively), expression of either mutant prevented the accelerated
transit of GLUT4myc through this compartment in response to insulin
(Fig. 8, l and n). These results suggest that both enzymes participate in the insulin-dependent
regulation of this aspect of GLUT4 traffic.

View larger version (17K):
[in a new window]
Fig. 9.
Internalized GLUT4myc is not significantly
detected in the TGN. L6-GLUT4myc myoblasts transfected to express
furin-CD25 were rounded-up and incubated for 10 min in the presence of
100 nM insulin at 37 °C during the re-attachment period.
The cells were then chilled, rinsed, and incubated for 1 h with
anti-Myc antibody in the absence of insulin as described under
"Experimental Procedures." After the wash steps, internalization
was allowed by switching the cells to 37 °C for the indicated time
periods. At each time point, the cells were fixed and stained with
secondary antibody. Shown are confocal micrographs of surface-labeled
GLUT4myc (red), whole-cell furin-CD25 (green),
and DNA (blue) after 0 (a), 10 (b),
and 20 min (c) of endocytosis. The open
arrowheads indicate furin-CD25 did not colocalize with GLUT4myc
(a-c). The compartments populated by furin-CD25
(green) and TfR (red) are distinct and can be
separated by confocal fluorescence microscopy (d). The area
outlined by the white box (d) was expanded 4× in
the inset, where the open arrowhead highlights
areas of no colocalization. The scale bar represents 10 µm. Shown are representative cells from one of two independent
experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit of PI 3-kinase
prevented the early arrival and departure of GLUT4myc to and from the
recycling endosome stimulated by insulin. Quantitation revealed that
treatment of cells with LY294002 alone had a slightly retarding effect
on the movement of GLUT4myc through the endosomal system. This is
consistent with previous reports that wortmannin slows
inter-endosomal movement of TfR (43, 44).
S caused GLUT4 budding out of a TGN-enriched
preparation in vitro (51). Our study suggests that the TGN
is not a stage in GLUT4 endocytosis and sorting in L6 myoblasts either
in the absence or presence of insulin, given that chased,
surface-labeled GLUT4 did not appear in the furin-containing
compartment (TGN).

View larger version (17K):
[in a new window]
Fig. 10.
Model of GLUT4 traffic and sites of insulin
input. The results of this study suggest the following model.
After removal from the plasma membrane, GLUT4 enters the early endosome
(EE) characterized by EEA1. From the early endosome GLUT4
can travel to the juxtanuclear, recycling endosome (RE)
marked by TfR or to specialized vesicles. Transit to the recycling
endosome is regulated by a PI 3-kinase- and PKB-dependent
signal from insulin. Future studies should investigate the localization
of GLUT4 after its exit from the recycling endosome in an attempt to
define the genesis of the specialized exocytic vesicles.
In a recent study (39) a lag time was noted between the disappearance from the plasma membrane of 3T3-L1 adipocytes of the IRAP, whose traffic closely parallels that of GLUT4, and its appearance in a low density microsome fraction previously shown to contain TfR. It is conceivable that the early endosome defined by EEA1 segregates from the low density microsomal fraction. In this way, the time differential between the disappearance of IRAP from the surface and its appearance in low density microsomes could be because of the transit of IRAP through the early endosome, as demonstrated here for GLUT4myc.
There is general agreement that increased GLUT4 insertion into the plasma membrane in response to insulin requires the action of PI 3-kinase (26, 29). In addition, several studies suggest that PKB also contributes to insulin action, including studies in L6 skeletal muscle cells (11, 52) and 3T3-L1 adipocytes (53). However, the precise point(s) of action of PI 3-kinase and PKB were unknown, since previous studies only used glucose uptake and/or a gain in GLUT4 in the plasma membrane as end point measurements to study the effects of perturbing PI 3-kinase or PKB mutants. The present study raises the hypothesis that insulin input is required at two distinct loci (entrance to and departure from the recycling endosome) and is consistent with a model whereby PI 3-kinase and PKB mediate both inputs. The overall effect of insulin on inter-endosomal GLUT4 traffic would be to expedite movement of GLUT4 through the endosomal system, presumably culminating in the genesis of the exocytic GLUT4 vesicles, which would then be mobilized to the plasma membrane where they would dock and fuse. Additional regulation of the movement of the vesicle and of its interaction with the plasma membrane is not ruled out by this study. Accelerated inter-endosomal transit would provide the cell with a means to maintain levels of plasma membrane GLUT4 in the presence of a continued insulin challenge by regulating the production of plasma membrane-destined GLUT4 vesicles.
An alternative possibility would be that, in the absence of insulin,
GLUT4 is sorted directly from the early endosomes to the sequestration
compartment. Upon insulin stimulation this compartment could be
envisaged to undergo fusion with the recycling compartment, from which
the vesicles that finally arrive at the plasma membrane would emanate.
Further rounds of GLUT4 traffic could conceivably bypass the
sequestration compartment altogether, thereby enhancing the rate of
GLUT4 recycling. Although this is also a very attractive model, it is
not borne out by the observation that tetanus toxin prevents
insulin-dependent incorporation of GLUT4 at the plasma membrane but does not alter the incorporation of GLUT4 either at the
basal state (i.e. during continuous recycling) or under conditions of hyperosmolarity stimulation of GLUT4 translocation (9,
14). One would have to consider that, if the recycling endosome is the
ultimate stop for GLUT4 before departing to the plasma membrane,
different vesicles must bud out from this compartment in the presence
or absence of insulin, which are differentiated by their dependence on
tetanus toxin-sensitive vesicle SNARES. Further studies should focus on
discerning among these different possibilities.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Timothy McGraw for helpful discussion and Drs. Heidi McBride, Marino Zerial, Mike Moran, Jim Woodgett, Julian Downward, Juan Bonifacino, Sergio Grinstein, Bill Trimble, Phil Bilan, and Zhi Liu for generous supplies of constructs, reagents, and advice.
| |
FOOTNOTES |
|---|
* This work was supported by Canadian Institutes for Health Research Grant MOP-7307 (to A. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Funded by a Canadian Institutes for Health doctoral studentship.
¶ Funded by a post-doctoral fellowship from the Banting and Best Diabetes Center, University of Toronto.
** Funded by a studentship from the Banting and Best Diabetes Center, University of Toronto.

To whom correspondence should be addressed: Program in Cell
Biology, The Hospital for Sick Children, 555 University Ave., Toronto,
Ontario, M5G 1X8, Canada. Tel.: 416-813-6392; Fax: 416-813-5028; E-mail: amira@sickkids.on.ca.
Published, JBC Papers in Press, September 17, 2001, DOI 10.1074/jbc.M102964200
2 L. Foster and A. Klip, unpublished observation.
3 R. Somwar and A. Klip, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
PI, phosphatidylinositol;
PKB, protein kinase B;
TfR, transferrin receptor;
PBS, phosphate-buffered saline;
IRAP, insulin-regulated aminopeptidase;
EEA1, early endosome antigen 1;
TGN, trans-Golgi network;
SNARE, N-ethylmaleimide-sensitive factor attachment protein
receptor protein;
GTP
S, guanosine
5'-3-O-(thio)triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Mukherjee, S.,
Ghosh, R. N.,
and Maxfield, F. R.
(1997)
Physiol. Rev.
77,
759-803 |
| 2. |
Satoh, S.,
Nishimura, H.,
Clark, A. E.,
Kozka, I. J.,
Vannucci, S. J.,
Simpson, I. A.,
Quon, M. J.,
Cushman, S. W.,
and Holman, G. D.
(1993)
J. Biol. Chem.
268,
17820-17829 |
| 3. | James, D. E., Strube, M., and Mueckler, M. (1989) Nature 338, 83-87[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | King, P. A., Horton, E. D., Hirshman, M. F., and Horton, E. S. (1992) J. Clin. Invest. 90, 1568-1575 |
| 5. | Zierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., and Wallberg-Henriksson, H. (1996) Diabetologia 39, 1180-1189[Medline] [Order article via Infotrieve] |
| 6. | Zierath, J. R., Krook, A., and Wallberg-Henriksson, H. (2000) Diabetologia 43, 821-835[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Wang, Q., Khayat, Z., Kishi, K., Ebina, Y., and Klip, A. (1998) FEBS Lett. 427, 193-197[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Ueyama, A.,
Yaworsky, K. L.,
Wang, Q.,
Ebina, Y.,
and Klip, A.
(1999)
Am. J. Physiol.
277,
E572-E578 |
| 9. |
Li, D.,
Randhawa, V. K.,
Patel, N.,
Hayashi, M.,
and Klip, A.
(2001)
J. Biol. Chem.
276,
22883-22891 |
| 10. | Clark, A. E., Holman, G. D., and Kozka, I. J. (1991) Biochem. J. 278, 235-241 |
| 11. |
Wang, Q.,
Somwar, R.,
Bilan, P. J.,
Liu, Z.,
Jin, J.,
Woodgett, J. R.,
and Klip, A.
(1999)
Mol. Cell. Biol.
19,
4008-4018 |
| 12. | Khayat, Z. A., Tong, P., Yaworsky, K., Bloch, R. J., and Klip, A. (2000) J. Cell Sci. 113, 279-290[Abstract] |
| 13. | Tong, P., Khayat, Z. A., Huang, C., Patel, N., Ueyama, A., and Klip, A. (2001) J. Clin. Invest. 108, 371-381[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Randhawa, V. K.,
Bilan, P. J.,
Khayat, Z. A.,
Daneman, N.,
Liu, Z.,
Ramlal, T.,
Volchuk, A.,
Peng, X. R.,
Coppola, T.,
Regazzi, R.,
Trimble, W. S.,
and Klip, A.
(2000)
Mol. Biol. Cell
11,
2403-2417 |
| 15. | Khayat, Z. A., Tsakiridis, T., Ueyama, A., Somwar, R., Ebina, Y., and Klip, A. (1998) Am. J. Physiol. 275, C1487-C1497 |
| 16. |
Bosshart, H.,
Humphrey, J.,
Deignan, E.,
Davidson, J.,
Drazba, J.,
Yuan, L.,
Oorschot, V.,
Peters, P. J.,
and Bonifacino, J. S.
(1994)
J. Cell Biol.
126,
1157-1172 |
| 17. |
Kanai, F.,
Nishioka, Y.,
Hayashi, H.,
Kamohara, S.,
Todaka, M.,
and Ebina, Y.
(1993)
J. Biol. Chem.
268,
14523-14526 |
| 18. |
Cheatham, B.,
Volchuk, A.,
Kahn, C. R.,
Wang, L.,
Rhodes, C. J.,
and Klip, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15169-15173 |
| 19. |
Jhun, B. H.,
Rampal, A. L.,
Liu, H.,
Lachaal, M.,
and Jung, C. Y.
(1992)
J. Biol. Chem.
267,
17710-17715 |
| 20. |
Subtil, A.,
Lampson, M. A.,
Keller, S. R.,
and McGraw, T. E.
(2000)
J. Biol. Chem.
275,
4787-4795 |
| 21. |
Garza, L. A.,
and Birnbaum, M. J.
(2000)
J. Biol. Chem.
275,
2560-2567 |
| 22. | Mu, J., Brozinick, J. T., Jr., Valladares, O., Bucan, M., and Birnbaum, M. J. (2001) Mol. Cell 7, 1085-1094[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Kawanaka, K.,
Han, D. H.,
Gao, J.,
Nolte, L. A.,
and Holloszy, J. O.
(2001)
J. Biol. Chem.
276,
20101-20107 |
| 24. |
Mu, F.-T.,
Callaghan, J. M.,
Steele-Mortimer, O.,
Stenmark, H.,
Parton, R. G.,
Campbell, P. L.,
McCluskey, J.,
Yeo, J.-P.,
Tock, E. P. C.,
and Toh, B.-H.
(1995)
J. Biol. Chem.
270,
13503-13511 |
| 25. | Witt, D. P., and Woodworth, R. C. (1978) Biochemistry 17, 3913-3917[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Cheatham, B.,
Vlahos, C. J.,
Cheatham, L.,
Wang, L.,
Blenis, J.,
and Kahn, C. R.
(1994)
Mol. Cell. Biol.
14,
4902-4911 |
| 27. | Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M., and Holman, G. D. (1994) Biochem. J. 300, 631-635 |
| 28. |
Okada, T.,
Kawano, Y.,
Sakakibara, T.,
Hazeki, O.,
and Ui, M.
(1994)
J. Biol. Chem.
269,
3568-3573 |
| 29. | Tsakiridis, T., McDowell, H., Walker, T., Downes, P., Hundal, H. S., Vranic, M., and Klip, A. (1995) Endocrinology 136, 4315-4322[Abstract] |
| 30. |
Yeh, J. I.,
Gulve, E. A.,
Rameh, L.,
and Birnbaum, M. J.
(1995)
J. Biol. Chem.
270,
2107-2111 |